LOTRONEX (Sebela Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the LOTRONEX drug offered from Sebela Pharmaceuticals Inc.. This Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sebela Pharmaceuticals Inc.
NON-PROPRIETARY NAME: alosetron hydrochloride
SUBSTANCE NAME: ALOSETRON HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-07-11
END MARKETING DATE: 0000-00-00


LOTRONEX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLOTRONEX from Sebela Pharmaceuticals Inc.
LABELER NAME: Sebela Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/1)
START MARKETING DATE: 2016-07-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54766-894_35cbb9d5-639a-207a-e054-00144ff88e88
PRODUCT NDC: 54766-894
APPLICATION NUMBER: NDA021107

Other ALOSETRON HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Alosetron Hydrochloride
Amneal Pharmaceuticals LLCAlosetron Hydrochloride
AvKARE, Inc.Alosetron Hydrochloride
Prometheus Laboratories Inc.LOTRONEX
Sebela Pharmaceuticals Inc.LOTRONEX
West-Ward Pharmaceuticals Corp.Alosetron Hydrochloride